JPMorgan Maintains Eli Lilly at Overweight, Raises Target to $1,650
JPMorgan raised its price target from $1,500 to $1,650 while maintaining its Overweight rating.
Story updates
10:24:20 PM UTC
SquawkNews
Eli Lilly Price Target Raised to $1650.00/Share From $1500.00 by JP Morgan